Citadel Securities Downgrades Savient Pharmaceuticals (SVNT) to Neutral; Krystexxa Ramp On Hold
Tweet Send to a Friend
Citadel Securities downgraded Savient Pharmaceuticals (NASDAQ: SVNT) to Neutral.
Citadel analyst says, "We do not anticipate a meaningful inflection in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citadel analyst says, "We do not anticipate a meaningful inflection in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
